GO
Loading...

Enter multiple symbols separated by commas

Food and Staples Retailing Drug Retail

More

  • Eli Lilly CEO: Hope to publish migraine data late 2014

    Eli Lilly Chairman & CEO John Lechleiter provides insight on its rights to an experimental migraine drug.

  • Eli Lilly CEO: Strongest late-phase pipeline in our history

    Eli Lilly Chairman & CEO John Lechleiter discusses its loss of major patents, its current pipeline and when its total costs will normalize.

  • The next big drug Monday, 13 Jan 2014 | 1:25 PM ET
    The next big drug

    CNBC's Morgan Brennan reports on the FDA's four expediting pipelines. The approval rates for the drugs in these pipelines tend to be higher than those plodding the more traditional course.

  • Children's top flu medicine in short supply in U.S. Thursday, 9 Jan 2014 | 5:56 PM ET

    But the delay in packaging the liquid version has not affected supplies of regular Tamiflu, said the Roche unit that makes the medication.

  • Neurocrine Biosciences CEO on TD treatment Tuesday, 7 Jan 2014 | 2:35 PM ET
    Neurocrine Biosciences CEO on stock spike

    Neurocrine Biosciences' president and CEO Kevin Gorman, Ph. D., provides insight on clinical trials for its tardive dyskinesia treatment.

  • High Times announces new fund Tuesday, 7 Jan 2014 | 2:27 PM ET
    High Times announces new fund

    CNBC's Josh Lipton reports on the HT Growth Fund, which plans to raise $100 million over the next two years for the legal marijuana market.

  • Tough business of marijuana Tuesday, 7 Jan 2014 | 12:51 PM ET
    Tough business of marijuana

    CNBC's Josh Lipton reports that legal recreational pot businesses could get investment from a fund.

  • Colorado pot: Lighting the licensing way Thursday, 26 Dec 2013 | 11:50 AM ET
    Colorado pot: Lighting the licensing way

    Colorado has issued more than 300 licenses to marijuana dispensaries. Dan Danko, High Times Magazine senior editor, discusses how Colorado is properly regulating pot distribution and explains the rigorous application process to obtain a license.

  • Under ACA, payments to doctors made public Tuesday, 17 Dec 2013 | 1:17 PM ET
    Under ACA, payments to doctors made public

    CNBC's Sara Eisen reports GlaxoSmithKline is becoming the first to stop paying doctors to promote drugs.

  • Cramer: ‘I’m throwing up my hands with this group’ Wednesday, 4 Dec 2013 | 11:16 AM ET

    Muddled by inconsistent earnings and stock performances, one sector appears tougher and tougher to predict, CNBC's Jim Cramer says.

  • Rocky Mountain High-er Friday, 22 Nov 2013 | 10:27 AM ET
    Denver store first to sell recreational pot legally

    A medical marijuana dispensary in Central City, Colo.—a small gambling town nestled in the mountains near Denver—just became the first business in the United States licensed to sell marijuana to patrons without a note from their doctors.

  • Third party sales pit Amazon vs. JNJ: Report Monday, 11 Nov 2013 | 8:37 AM ET

    Amazon.com is clashing with Johnson & Johnson amid complaints the online retailer hasn't stopped sales of damaged or expired products.

  • NPS Pharma CEO talks life changing treatment

    Francois Nader, NPS Pharmaceuticals president & CEO, discusses its lead product Gattex for "short bowel syndrome," the potential for Netpara and the solid performance of its stock.

  • 'Pot Mom' pleads guilty Wednesday, 9 Oct 2013 | 1:32 PM ET
    'Pot Mom' pleads guilty

    The so-called "pot mom" Andrea Sanderlin has confessed to a judge she operated a facility in which she and others grew at least 1,000 marijuana plants and sold the products. CNBC's Andrea Day has the details.

  • Drugstores aim to be one-stop Obamacare shop Thursday, 3 Oct 2013 | 11:47 AM ET
    A sign offering help for customers with questions about the Affordable Care Act hangs in a pharmacy in Wheeling, Illinois.

    Drugstores signed on to help educate consumers about Obamacare, but they have their sights set on the future business of these newly insured consumers.

  • L'Oreal on Nestle deal: 'This is business fiction' Friday, 30 Aug 2013 | 2:01 AM ET
    Jean-Paul Agon, chief executive officer of L'Oreal SA

    L'Oreal's rumored buyback of Nestle's 29.5 percent stake in the French cosmetics giant looked far from a done deal on Friday, with Jean-Paul Agon, chairman and CEO of L'Oreal, telling CNBC that the ball was in the Swiss food giant's court.

  • DOJ will not block state pot laws Thursday, 29 Aug 2013 | 2:49 PM ET
    DOJ will not block state pot laws

    The Department of Justice will not block state marijuana laws if distribution is regulated, reports CNBC's Eamon Javers.

  • Scammers target pot stocks Tuesday, 20 Aug 2013 | 1:58 PM ET
    Scammers target pot stocks

    FINRA is issuing a new investor alert called "marijuana stock scams." CNBC's Mary Thompson offers insight.

  • 'High' taxes Thursday, 15 Aug 2013 | 1:55 PM ET
    'High' taxes

    Washington will tax pot anywhere from 25 to 50 percent at the production and processor level, another 25 percent at retail. CNBC's Jane Wells reports Washington says it could raise up to $2 billion in pot taxes over five years.

  • Pot entrepreneurs invest in the 'green rush' Thursday, 15 Aug 2013 | 12:00 AM ET
    Pot entrepreneurs invest in the 'green rush'

    CNBC's Jane Wells reports from the River Rock Wellness Center in Denver, Colorado, where in 5 months legal medical cannabis will be able to be sold as recreational pot. Investors are hoping to cash in on the "green rush," she says.